Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms

ClinicalTrials.gov ID: NCT05407064

Public ClinicalTrials.gov record NCT05407064. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 3:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multi-center, Randomized, Double-Blind, Parallel-Group, Dose-Finding Study to Assess the Effect of Four Doses of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2, multi-center, randomized, double-blind, parallel-group, dose-finding study to assess the effect of 4 doses of MM120 (25, 50, 100 or 200 μg freebase-equivalent) for the treatment of anxiety symptoms in subjects diagnosed with generalized anxiety disorder (GAD).

Study identification

NCT ID
NCT05407064
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Definium Therapeutics US, Inc.
Industry
Enrollment
198 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 24, 2022 (Actual)
Primary completion
Oct 6, 2023 (Actual)
Completion
Nov 27, 2023 (Actual)
Last update posted
Feb 27, 2026

2022 – 2023

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
21
Facility City State ZIP Site status
Preferred Research Partners Little Rock Arkansas 72211 —
Irvine Center for Clinical Research Irvine California 92614 —
Kadima Neuropsychiatry Institute La Jolla California 92037 —
Pacific Neuroscience Institute Santa Monica California 90404 —
Mountain View Clinical Research Denver Colorado 80209 —
Wholeness Center Fort Collins Colorado 80525 —
Segal Trials Lauderhill Florida 33319 —
CNS Healthcare - Orlando Orlando Florida 32801 —
iResearch Atlanta Decatur Georgia 30030 —
Great Lakes Clinical Trials Chicago Illinois 60640 —
Uptown Research Chicago Illinois 60640 —
Sunstone Therapies Rockville Maryland 20850 —
SISU Springfield Massachusetts 01103 —
Adams Clinical Watertown Massachusetts 02472 —
Hassman Research Institute Berlin New Jersey 08009 —
GMI - Princeton Medical Institute Princeton New Jersey 08540 —
Lutheran Hospital - Cleveland Clinic Cleveland Ohio 44113 —
BioBehavioral Research of Austin Austin Texas 78759 —
University of Texas Health Houston Houston Texas 77054 —
Cedar Clinical Research Draper Utah 84020 —
Cedar Clinical Research - Murray Murray Utah 84107 —
Woodstock Research Center Woodstock Vermont 05091 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05407064, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 27, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05407064 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →